These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 32891070)
1. Long non-coding RNA 00507/miRNA-181c-5p/TTBK1/MAPT axis regulates tau hyperphosphorylation in Alzheimer's disease. Yan Y; Yan H; Teng Y; Wang Q; Yang P; Zhang L; Cheng H; Fu S J Gene Med; 2020 Dec; 22(12):e3268. PubMed ID: 32891070 [TBL] [Abstract][Full Text] [Related]
2. miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease. Li J; Chen W; Yi Y; Tong Q J Cell Biochem; 2019 Jun; 120(6):9936-9946. PubMed ID: 30556160 [TBL] [Abstract][Full Text] [Related]
3. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells. Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687 [TBL] [Abstract][Full Text] [Related]
4. Tau-tubulin kinase 1 and amyloid-β peptide induce phosphorylation of collapsin response mediator protein-2 and enhance neurite degeneration in Alzheimer disease mouse models. Ikezu S; Ingraham Dixie KL; Koro L; Watanabe T; Kaibuchi K; Ikezu T Acta Neuropathol Commun; 2020 Feb; 8(1):12. PubMed ID: 32019603 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of miR-26a-5p Suppresses Tau Phosphorylation and Aβ Accumulation in the Alzheimer's Disease Mice by Targeting DYRK1A. Liu Y; Wang L; Xie F; Wang X; Hou Y; Wang X; Liu J Curr Neurovasc Res; 2020; 17(3):241-248. PubMed ID: 32286945 [TBL] [Abstract][Full Text] [Related]
6. MiR-539-5p Decreases amyloid β-protein production, hyperphosphorylation of Tau and Memory Impairment by Regulating PI3K/Akt/GSK-3β Pathways in APP/PS1 Double Transgenic Mice. Jiang Y; Zhang Y; Su L Neurotox Res; 2020 Aug; 38(2):524-535. PubMed ID: 32415525 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-181c-5p in Alzheimer's disease weakens the response of microglia to Aβ phagocytosis. Li R; Yao S; Wei F; Chen M; Zhong Y; Zou C; Chen L; Wei L; Yang C; Zhang X; Liu Y Sci Rep; 2024 May; 14(1):11487. PubMed ID: 38769091 [TBL] [Abstract][Full Text] [Related]
9. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation. Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667 [TBL] [Abstract][Full Text] [Related]
10. Candidate Alzheimer's Disease Biomarker miR-483-5p Lowers TAU Phosphorylation by Direct ERK1/2 Repression. Nagaraj S; Want A; Laskowska-Kaszub K; Fesiuk A; Vaz S; Logarinho E; Wojda U Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915734 [TBL] [Abstract][Full Text] [Related]
11. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease. Liu W; Zhao J; Lu G Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374 [TBL] [Abstract][Full Text] [Related]
12. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease. Wang D; Fei Z; Luo S; Wang H Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672 [TBL] [Abstract][Full Text] [Related]
13. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice. Zhou D; Liu H; Li C; Wang F; Shi Y; Liu L; Zhao X; Liu A; Zhang J; Wang C; Chen Z Metab Brain Dis; 2016 Jun; 31(3):693-703. PubMed ID: 26883430 [TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotide-based targeting of Tau-tubulin kinase 1 prevents hippocampal accumulation of phosphorylated tau in PS19 tauopathy mice. Yukawa K; Yamamoto-Mcguire S; Cafaro L; Hong C; Kamme F; Ikezu T; Ikezu S Acta Neuropathol Commun; 2023 Oct; 11(1):166. PubMed ID: 37853497 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic transcripts of LINC01311 and hsa-miR-146a-5p regulate neural development in a cellular model of Alzheimer's disease. Fan Y; Zhang J; Zhuang X; Geng F; Jiang G; Yang X IUBMB Life; 2021 Jul; 73(7):916-926. PubMed ID: 33830627 [TBL] [Abstract][Full Text] [Related]
17. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology. Sierksma A; Lu A; Salta E; Vanden Eynden E; Callaerts-Vegh Z; D'Hooge R; Blum D; Buée L; Fiers M; De Strooper B Mol Neurodegener; 2018 Oct; 13(1):54. PubMed ID: 30314521 [TBL] [Abstract][Full Text] [Related]
18. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study. Zhang ZX; Zhao RP; Wang DS; Wang AN Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601 [TBL] [Abstract][Full Text] [Related]
19. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease. Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414 [TBL] [Abstract][Full Text] [Related]
20. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β. Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]